SOUTH SAN FRANCISCO, Calif and VANCOUVER, Canada , Aug. 6, 2025 /PRNewswire/ -- ESSA Pharma Inc. (" ESSA ," or the " Company ") (NASDAQ: EPIX) today announced that, following the Company's receipt of an order from the Supreme Court of British Columbia (the " Court ") on August 5, 2025 , authorizing a reduction in the capital of the common shares of the Company (the " Common Shares " and the holders of such Common Shares, the " Shareholders ") and concurrent distribution to the Shareholders, the board of directors of the Company (the " Board ") has approved a return of capital distribution in the aggregate amount of US$80,000,000 (the " Distribution ") to the Shareholders as part of the discontinuance and winding-up of the business of the Company.

The Distributi

See Full Page